SCHEMBL6272666

SCHEMBL6272666

CCCCCC/C=C/Oc1c(O)c2c(OCCC(=O)O)cccc2oc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.39
▸ CDC25A P30304 1/20 0.37
▸ CDC25B P30305 1/20 0.37
▸ CDC25C P30307 1/20 0.37
▸ LTB4R Q15722 2/20 0.37
▸ CYSLTR2 Q9NS75 3/20 0.36
▸ CYSLTR1 Q9Y271 3/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ FAAH O00519 4/20 0.36
▸ CES1 P23141 2/20 0.36
▸ DAGLA Q9Y4D2 1/20 0.36
▸ POLM Q9NP87 1/20 0.36
▸ POLK Q9UBT6 1/20 0.36
▸ POLL Q9UGP5 1/20 0.36
▸ POLH Q9Y253 1/20 0.36
▸ NQO1 P15559 1/20 0.36
▸ PLA2G4B P0C869 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN7 P35236 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272674 1.00 EPHX2 (0.39) EPHX2CDC25ACDC25BCDC25CLTB4R
SCHEMBL6276744 0.95 EPHX2 (0.43) EPHX2LTB4RPPARAFAAHDUSP3
SCHEMBL6276746 0.95 EPHX2 (0.43) EPHX2LTB4RPPARAFAAHDUSP3
SCHEMBL6277084 0.92 PPARA (0.42) EPHX2PPARAFAAHCES1DAGLA
SCHEMBL6277080 0.92 PPARA (0.42) EPHX2PPARAFAAHCES1DAGLA
SCHEMBL6270793 0.92 PPARA (0.42) EPHX2PPARAFAAHCES1DAGLA
SCHEMBL6270790 0.92 PPARA (0.42) EPHX2PPARAFAAHCES1DAGLA
SCHEMBL6277171 0.90 NQO1 (0.38) NQO1
SCHEMBL6277169 0.90 NQO1 (0.38) NQO1
SCHEMBL6272736 0.90 NQO1 (0.38) NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 EPHX2 2989/4885CDC25A 2573/4885CDC25B 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback